Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Net Margin: 2009-2025

Historic Net Margin for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -5.62%.

  • Lifecore Biomedical's Net Margin rose 1308.00% to -5.62% in Q2 2025 from the same period last year, while for May 2025 it was -34.42%, marking a year-over-year decrease of 3415.00%. This contributed to the annual value of -34.42% for FY2025, which is 4379.00% down from last year.
  • As of Q2 2025, Lifecore Biomedical's Net Margin stood at -5.62%, which was up 88.64% from -49.44% recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Net Margin registered a high of 43.78% during Q1 2024, and its lowest value of -183.73% during Q2 2022.
  • For the 3-year period, Lifecore Biomedical's Net Margin averaged around -25.27%, with its median value being -22.71% (2024).
  • In the last 5 years, Lifecore Biomedical's Net Margin tumbled by 17,909bps in 2022 and then spiked by 17,639bps in 2023.
  • Over the past 5 years, Lifecore Biomedical's Net Margin (Quarterly) stood at -179.75% in 2021, then surged by 16,326bps to -16.49% in 2022, then slumped by 1,918bps to -35.67% in 2023, then soared by 894bps to -26.73% in 2024, then skyrocketed by 1,308bps to -5.62% in 2025.
  • Its last three reported values are -5.62% in Q2 2025, -49.44% for Q1 2025, and -26.73% during Q4 2024.